Clinical Trial Update: NicVAX/Placebo as an Aid for Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating NicVAX (vaccine) vs placebo for smoking cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NicVAX (nicotine vaccine)

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Smoking Cessation, Smoking | Phase 3 | Status: COMPLETED